Topic: Staphylococcus aureus

Could a trio of new vaccines make up for Prevnar at Pfizer?

Monday, May 7, 2018

Pfizer has three vaccine programs in development—and top executives have high hopes—but two key programs have competitors close behind.

Tuesday, April 10, 2018

Behind the under-pressure blockbuster Prevnar 13 are several pipeline vaccines Pfizer hopes will propel future growth.

Wednesday, January 31, 2018

Pfizer's Prevnar turned in consensus-beating sales of $1.53 billion in Q4, thanks to government purchases internationally and in the U.S.